The Montreal Clinical Research Institute (IRCM) is happy to underline that the work of Dr. Jennifer Estall, Director of the Molecular Mechanisms of Diabetes Research Unit at IRCM, has been featured in a spotlight article published in the May 2026 issue of Diabetes, one of the world’s leading journals in metabolic disease research.
“This spotlight highlights the significance and impact of Dr. Estall’s research and its contribution to advancing our understanding of diabetes and metabolic health. Her work reflects IRCM’s strength in conducting rigorous, innovative research that bridges fundamental discovery and clinical relevance’’, noted Dr. Jean-François Côté, President and Scientific Director at IRCM.
Published by the American Diabetes Association, Diabetes is an internationally respected journal that disseminates influential research shaping the future of diabetes prevention, diagnosis, and treatment. Being selected for a spotlight feature underscores the scientific excellence of Dr. Estall’s work and its relevance to the broader biomedical community.
Jennifer Estall’s research unit focuses on understanding the pathogenesis of diabetes at the molecular level. This metabolic disease afflicts millions of people worldwide, yet we still do not know the underlying cause. Diabetes affects many organ systems, including pancreas, liver, muscle, fat, bone, and brain, each playing a distinct role in disease etiology.
In Jennifer Estall's laboratory, members of the team strive to understand the molecular events in each tissue that trigger disease and identify new ways to prevent, diagnose, or reverse the metabolic abnormalities associated with insulin resistance and beta-cell dysfunction / death.
The May 2026 issue of Diabetes is now available and showcases cutting edge research from leading scientists worldwide, including this notable contribution from IRCM’s Jennifer Estall and collaborators.
Read the study: Diabetes Spotlight: Jennifer Estall, PhD—Identifying Signals Between the Pancreas and Liver
